Patents by Inventor Gretchen B. Wojcik

Gretchen B. Wojcik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9114162
    Abstract: Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Microspheres of the present invention may further be provided with physical and/or chemical enhancements within the particles' cores to enhance visualization of the embolized tissue using a variety of medical imaging modalities, including conventional radiography, fluoroscopy, tomography, computerized tomography, ultrasound, scintillation, magnetic resonance, or other imaging technologies.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: August 25, 2015
    Assignee: CELONOVA BIOSCIENCES, INC.
    Inventors: Ulf Fritz, Olaf Fritz, Thomas A. Gordy, Jacques Blümmel, Alexander Küller, Gretchen B. Wojcik
  • Patent number: 9107850
    Abstract: Polymeric particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Particles of the present invention may further be provided as color-coded microspheres or nanospheres to allow ready identification of the sized particles in use. Such color-coded microspheres or nanospheres may further be provided in like color-coded delivery or containment devices to enhance user identification and provide visual confirmation of the use of a specifically desired size of microspheres or nanospheres.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: August 18, 2015
    Assignee: CELONOVA BIOSCIENCES, INC.
    Inventors: Ulf Fritz, Olaf Fritz, Thomas A. Gordy, Jacques Blümmel, Alexander Küller, Gretchen B. Wojcik